Cui'e Lu Selected Research

JHW 015

1/2017	A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2.
10/2015	Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cui'e Lu Research Topics

Disease

9	Hyperalgesia 01/2022 - 05/2015
6	Pain (Aches) 01/2022 - 05/2015
4	Bone Neoplasms (Bone Cancer) 01/2022 - 10/2015
3	Postoperative Pain 11/2021 - 05/2015
2	Surgical Wound 01/2017 - 05/2015
1	Neuroinflammatory Diseases 01/2022
1	Neoplasms (Cancer) 01/2016
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2016
1	Carcinoma (Carcinomatosis) 10/2015
1	Inflammation (Inflammations) 10/2015
1	Neuralgia (Stump Neuralgia) 10/2015

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2017 - 10/2015
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2016
2	Remifentanil (Ultiva)FDA Link 01/2017 - 05/2015
2	Minocycline (Cyclops)FDA LinkGeneric 01/2017 - 01/2016
2	JHW 015IBA 01/2017 - 10/2015
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 10/2015
1	Long Noncoding RNAIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	erythromycin propionate-N-acetylcysteinateIBA 11/2021
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	Sincalide FDA Link 01/2019
1	YM 022IBA 01/2019
1	1- (5- (2- thenyloxy)- 1H- indol- 3- yl)propan- 2- amineIBA 01/2019
1	2- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA 01/2019
1	Cholecystokinin (Pancreozymin)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Cholecystokinin B ReceptorIBA 01/2019
1	5-HT2B Serotonin ReceptorIBA 01/2019
1	GlucocorticoidsIBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	CannabinoidsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	CB2 Cannabinoid ReceptorIBA 01/2017
1	InterleukinsIBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	bovine adrenal medulla 8-22IBA 01/2016
1	Interleukin-18 (Interleukin 18)IBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2015
1	RE1-silencing transcription factorIBA 05/2015
1	Antisense OligonucleotidesIBA 05/2015
1	mu Opioid Receptors (mu Opioid Receptor)IBA 05/2015

Therapy/Procedure

4	Spinal Injections 11/2021 - 10/2015
2	Therapeutics 01/2017 - 05/2015
1	Anesthesia 01/2017
1	Electroacupuncture 01/2017
1	Intraperitoneal Injections 01/2017
1	Subcutaneous Infusions 05/2015